# VERTEX PHARMACEUTICA (VRTX) — Q4-2016 Earnings Results

**Report date:** 2017-01-25 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/VRTX/earnings/Q4-2016

## Post-Earnings Brief

### Headline

Vertex Pharmaceuticals Beats on EPS, Stock Up 3.59%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.35 | N/A | +5100.00% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Vertex Pharmaceuticals reported a significant earnings surprise with an EPS of $0.35, which drove the stock up by 3.59%. However, there was no revenue reported or guidance provided, leaving investors with limited insight into future performance. The strong EPS figure suggests that the company may be managing costs effectively or benefiting from favorable conditions in its operations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/VRTX/earnings/Q4-2016_